Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A0BL849
Fri, 19.04.2024
Vita 34 AG
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures
Leipzig, 19 April 2024 – According to the final key financial figures for fiscal year 2023 available today, Vita 34 AG closed the year significantly better in terms of earnings than expected by the Management Board on the basis of the preliminary busin [ … ]
Wed, 31.01.2024
Vita 34 AG
Vita 34 publishes preliminary figures on the course of business in 2023
Leipzig, 31 January 2024 - Vita 34 AG closed the year 2023, in view of a challenging environment, solidly from a purely operational perspective. However, a number of extraordinary charges caused the earnings development to fall short of expectations.
Based on initial prelimin [ … ]
Tue, 02.01.2024
Vita 34 AG
Vita 34 downsizes Management Board until further notice
CFO Dirk Plaga stepped down from the Management Board as of 31 December 2023
Management Board to be temporarily reduced from three to two members
Leipzig, 2 January 2024 – Vita 34 AG, the leading cell bank in Europe and the third largest in the world, is making changes to its Management Boar [ … ]
Mon, 27.11.2023
Vita 34 AG
THE INFORMATION CONTAINED IN THIS ANNOUNCEMENT IS NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL.
Vita 34 AG resolves on cash capital increase under exclusion of subscription rights in the amount of up t [ … ]
Fri, 24.11.2023
Vita 34 AG
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development
Revenues increased solidly by 11.7 percent to EUR 56.7 million in the first nine months of 2023
Adjusted pricing models and internal efficiency programs provide positive impetus
EBITDA further improved versus last year and versus Q2 to EUR 3.6 million
[ … ]
Fri, 10.11.2023
Vita 34 AG
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements
Leipzig, 10 November 2023 - Based on an internal notice, Vita 34 AG has conducted an investigation at one of its small subsidiaries. This revealed potential irre [ … ]
Wed, 27.09.2023
Vita 34 AG
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor
Leipzig, [27 Sept 2023] – Polski Bank Komórek Macierzystych (“PBKM”), a fully owned subsidiary of Vita 34 AG announced on January 2, 2020, that PBKM´s subsidiary FamiCor [ … ]
Thu, 31.08.2023
Vita 34 AG
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings
Revenues in the first half of 2023 up 13.0 percent to EUR 36.3 million
EBITDA significantly increased to EUR 1.6 million compared with both the previous year and the first quarter of 2023
Operating cash flow significantly improved to EUR 2.9 million
G [ … ]
Wed, 31.05.2023
Vita 34 AG
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
First quarter sales up 15.7 percent to EUR 17.9 million
Gross profit benefits from price adjustments and cost discipline and increases by 58.2 percent to EUR 5.7 million
EBITDA in positive territory at EUR 0.3 million after significantly [ … ]
Wed, 31.05.2023
Vita 34 AG
Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment
First quarter sales up 15.7 percent to EUR 17.9 million
Gross profit benefits from price adjustments and cost discipline and increases by 58.2 percent to EUR 5.7 million
EBITDA in positive territory at EUR 0.3 million after significantly [ … ]